3,415
Views
10
CrossRef citations to date
0
Altmetric
Brief Report

Late diagnosis of Lesch–Nyhan disease complicated with end-stage renal disease and tophi burst: a case report

, , , , , & show all
Pages 113-121 | Received 06 Aug 2019, Accepted 27 Dec 2019, Published online: 27 Jan 2020

References

  • Hamosh A. Lesch-Nyhan syndrome; LNS [Internet]. Online Mendelian Inherit. Man. 2017; [cited 2018 Nov 12]. Available from: https://www.omim.org/entry/300322.
  • Nyhan WL, O’Neill JP, Jinnah HA, et al. Lesch-Nyhan syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle (WA): University of Washington; 2014.
  • Puig JG, Jimenez RT. Lesch Nyhan syndrome [Internet]. Orphanet. 2010; [cited 2018 Nov 12]. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=510.
  • Chiong MA, Marinaki A, Duley J, et al. Lesch-Nyhan disease in a 20-year-old man incorrectly described as developing “cerebral palsy” after general anaesthesia in infancy. J Inherit Metab Dis. 2006;29(4):594–594.
  • McCarthy GT, Green EM, Ogunbona O, et al. A population study of Lesch-Nyhan disease in the UK. Dev Med Child Neurol. 2011;53(1):34–29.
  • Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006;129(5):1201–1217.
  • Fu R, Chen C-J, Jinnah HA. Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease. Mol Genet Metab. 2014;112(4):280–285.
  • Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis. 2007;2:48.
  • de Brouwer APM, Duley JA, Christodoulou J. Phosphoribosylpyrophosphate synthetase superactivity. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 2015.
  • Oh TR, Choi HS, Kim CS, Bae EH, et al. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep. 2019;9(1):6681.
  • Gasperini S, Stagi S, Gasperini U, et al. Orange-colored diapers as first sign of Lesch-Nyhan disease in an asymptomatic infant. Pediatr Nephrol. 2010;25(11):2373–2374.
  • Ko EJ, Sung Y, Lee BH, et al. Lesch-Nyhan syndrome, a disease that could be easily missed: case series. Int Phys Med Rehab J. 2018;3:316‒319.
  • Torres RJ, Puig JG, Jinnah HA. Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr Rheumatol Rep. 2012;14(2):189–194.
  • Doucet BP, Jegatheesan D, Burke J. Late diagnosis of Lesch-Nyhan disease variant. BMJ Case Rep. 2013;2013:bcr2013201997.
  • Abhishek A, Valdes AM, Jenkins W, et al. Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study. PLoS One. 2017;12(10):e0186096.
  • Kumthekar A, Johnson B. Polyarticular severe tophaceous gout secondary to limited medication access. J Rheumatol. 2015;42(8):1528–1529.
  • Mandokhel R, Pritchard G, Jones J. Gouty tophi: here today gone tomorrow. Rheumatology. 2015;54(2):256–256.
  • Verma S, Bhargav P, Toprani T, et al. Multiarticular tophaceous gout with severe joint destruction: a pictorial overview with a twist. Indian J Dermatol. 2014;59(6):609–611.
  • Ankem M, Glazier DB, Barone JG. Lesch-Nyhan syndrome presenting as acute renal failure secondary to obstructive uropathy. Urology. 2000;56(6):1056.
  • Pela I, Donati MA, Procopio E, et al. Lesch-Nyhan syndrome presenting with acute renal failure in a 3-day-old newborn. Pediatr Nephrol. 2008;23(1):155–158.
  • Roxe DM. Urinalysis. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston (MA): Butterworths; 1990. Chapter 191.
  • Jinnah HA, Visser JE. Mutations database [Internet]. Lesch-Nyhan.org. 2018. [cited 2018 Nov 8]. Available from: http://www.lesch-nyhan.org/en/research/mutations-database.
  • Fu R, Ceballos-Picot I, Torres RJ, et al. Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain A J Neurol. 2014;137(5):1282–1303.
  • Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metab Clin Exp. 2007;57:1179–1186.
  • Walters S, Porter C, Brophy PD. Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol. 2009;24(1):37–48.
  • Feng S, Jiang L, Shi Y, et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2013;37(2–3):181–189.
  • Khasnavis T, Torres RJ, Sommerfeld B, et al. A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease. Mol Genet Metab. 2016;118(3):160–166.
  • Harris JC. Lesch-Nyhan syndrome and its variants: examining the behavioral and neurocognitive phenotype. Curr Opin Psychiatry. 2018;31(2):96–102.
  • Olson L, Houlihan D. A review of behavioral treatments used for Lesch-Nyhan syndrome. Behav Modif. 2000;24(2):202–222.
  • Vargiami E, Printza N, Papadimiditriou E, et al. Nephrocalcinosis and renal failure in Lesch-Nyhan syndrome: report of two familial cases and review of the literature. Urology. 2016;97:194–196.
  • Kim SJ, Sohn YB, Park SW, et al. Chronic peritoneal dialysis in a 4-year-old boy with Lesch–Nyhan disease. Pediatr Nephrol. 2009;24(5):1089–1090.